Subscribe to RSS
DOI: 10.1055/s-2006-939693
Synthesis of Novel Bicyclic Ketals of Galacturonic Acid as Potential Glycosidase Inhibitors
Publication History
Publication Date:
24 April 2006 (online)
Abstract
A synthesis of novel bicyclic ketals of galacturonic acid is described. The key cyclisation step was realised under acidic anhydrous conditions in very good yield. X-ray crystal structure analysis determined the correct regio- and stereochemistry.
Key words
galactose - glycosidase inhibitors - bicyclic acetal/ketal - lactol Wittig reaction - δ-amino acids
-
2a
Asano N. Glycobiology 2003, 13: 93R -
2b
Houston TA.Blanchfield JT. Mini-Rev. Med. Chem. 2003, 3: 669 -
2c
Chang C.-F.Ho C.-W.Wu C.-Y.Chao T.-A.Wong C.-H.Lin C.-H. Chem. Biol. 2004, 11: 1301 -
2d
Pearson MSM.Mathé-Allainmat M.Fargeas V.Lebreton J. Eur. J. Org. Chem. 2005, 2159 -
3a
Puls W.Keup U.Krause HP.Thomas G.Hoffmeister F. Naturwissenschaften 1977, 64: 536 -
3b
Mitrakou A.Tountas N.Raptis AE.Bauer RJ.Schulz H.Raptis SA. Diabetic Med. 1998, 15: 657 -
3c
Sels J.-PJE.Huijberts MSP.Wolffenbuttel BHR. Expert Opin. Pharmaco. 1999, 1: 149 -
3d
Scott LJ.Spencer CM. Drugs 2000, 59: 521 -
3e
Drent ML.Tollefsen ATM.van Heusden FHJA.Hoenderdos EBM.Jonker JJC.van der Veen EA. Diabetes Nutr. Metab. 2002, 15: 152 -
3f
Beck R. PharmaChem 2003, 2: 14 -
4a
Laver WG.Bischofberger N.Webster RG. Sci. Am. 1999, 280: 78 -
4b
Lew W.Chen X.Kim CU. Curr. Med. Chem. 2000, 7: 663 - 5
Zitzmann N.Mehta AS.Carrouée S.Butters TD.Platt FM.McCauley J.Blumberg BS.Dwek RA.Block TM. Proc. Natl. Acad. Sci. U. S. A. 1999, 96: 11878 - 6
Robina I.Moreno-Vargas AJ.Carmona AT.Vogel P. Curr. Drug Metab. 2004, 5: 329 - 7
Nishimura Y. Curr. Top. Med. Chem. 2003, 3: 575 -
8a
Douglas KT. Chem. Ind. 1983, 311 -
8b
Schramm VL. Annu. Rev. Biochem. 1998, 67: 693 -
8c
Schröder PN.Giannis A. Angew. Chem. Int. Ed. 1999, 38: 1379 ; Angew. Chem. 1999, 111, 1471 -
8d
Lillelund VH.Jensen HH.Liang X.Bols M. Chem. Rev. 2002, 102: 515 -
9a
Heightman TD.Vasella AT. Angew. Chem. Int. Ed. 1999, 38: 750 ; Angew. Chem. 1999, 111, 794 -
9b
Zechel DL.Boraston AB.Gloster T.Boraston CM.Macdonald JM.Tilbrook DMG.Stick RV.Davies GJ. J. Am. Chem. Soc. 2003, 125: 14313 -
10a
Sinnott ML. Chem. Rev. 1990, 90: 1171 -
10b
Zechel DL.Withers SG. Acc. Chem. Res. 2000, 33: 11 -
10c
Vasella A.Davies GJ.Böhm M. Curr. Opin. Chem. Biol. 2002, 6: 619 -
10d
Davies GJ.Ducros VM.-A.Varrot A.Zechel DL. Biochem. Soc. Trans. 2003, 31: 523 -
11a
Lorthiois E.Meyyappan M.Vasella A. Chem. Commun. 2000, 1829 -
11b
Fuentes J.Gasch C.Olano D.Pradera MA.Repetto G.Sayago FJ. Tetrahedron: Asymmetry 2002, 13: 1743 -
11c
Böhm M.Lorthiois E.Meyyappan M.Vasella A. Helv. Chim. Acta 2003, 86: 3787 -
11d
Böhm M.Lorthiois E.Meyyappan M.Vasella A. Helv. Chim. Acta 2003, 86: 3818 -
11e
Moreno-Vargas AJ.Schütz C.Scopelliti R.Vogel P. J. Org. Chem. 2003, 68: 5632 -
11f
Böhm M.Vasella A. Helv. Chim. Acta 2004, 87: 2566 -
11g
Blériot Y.Vadivel SK.Herrera AJ.Greig IR.Kirby AJ.Sinaӱ P. Tetrahedron 2004, 60: 6813 -
11h
Kapferer P.Vasella A. Helv. Chim. Acta 2004, 87: 2764 -
11i
Buser S.Vasella A. Helv. Chim. Acta 2005, 88: 3151 -
12a
Wolfrom ML.Thompson A. Methods Carbohyd. Chem. 1963, 2: 211 -
12b
Konstantinovic S.Dimitrijevic B.Radulovic V. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2002, 41: 598 - 13
Liu M.-Z.Fan H.-N.Guo Z.-W.Hui Y.-Z. Carbohydr. Res. 1996, 290: 233 - 14
Ohlsson J.Magnusson G. Carbohydr. Res. 2000, 329: 49 - 15
Wong C.-H.Moris-Varas F.Hung S.-C.Marron TG.Lin C.-C.Gong KW.Weitz-Schmidt G. J. Am. Chem. Soc. 1997, 119: 8152 -
16a
Gigg J.Gigg R. J. Chem. Soc. 1966, 82 -
16b
Koeman FAW.Kamerling JP.Vliegenthart JFG. Tetrahedron 1993, 49: 5291 - 17
Plettenburg O.Bodmer-Narkevitch V.Wong C.-H. J. Org. Chem. 2002, 67: 4559 - 18
RajanBabu TV.Fukunaga T.Reddy GS. J. Am. Chem. Soc. 1989, 111: 1759 - 20
van Heeswijk WAR.Goedhart JB.Vliegenthart JFG. Carbohydr. Res. 1977, 58: 337 -
22a
De Mico A.Margarita R.Parlanti L.Vescovi A.Piancatelli G. J. Org. Chem. 1997, 62: 6974 -
22b
Vescovi A.Knoll A.Koert U. Org. Biomol. Chem. 2003, 1: 2983
References and Notes
Current address: Polyphor AG, Gewerbestr. 14, 4123 Allschwil (BL), Switzerland.
19
Preparation of (2
R
,3
S
,4
R
,5
S
)-4,5-Di-
O
-benzyl-1,3-
O
-benzylidenehept-6-ene-1,2,3,4,5-pentaol.
A suspension of 4.79 g (13.4 mmol, 4.0 equiv) methyltri-phenylphosphonium bromide (purchased and stored in vacuo over P2O5) in 70 mL dry THF was cooled to -30 °C and 7.9 mL of a solution of n-BuLi in hexane (1.6 M, 12.7 mmol, 3.8 equiv) were added dropwise with a syringe. The reaction mixture turned to a clear yellow solution within 20 min. At the same temperature a solution of 1.50 g (3.35 mmol, 1.0 equiv) lactol 5 in 30 mL dry THF was added dropwise with a syringe. The syringe was washed with 2 × 2 mL THF. The reaction mixture was stirred for 24 h while the temperature gradually came to r.t. The resulting orange suspension was quenched with 100 mL H2O and the layers were seperated. The aqueous layer was neutralised with 100 mL sat. NH4Cl and extracted with 3 × 80 mL MTBE. The combined organic layers were washed with 2 × 50 mL sat. NH4Cl, 50 mL H2O and 50 mL brine, dried over MgSO4 and the solvents were evaporated. The remaining sticky yellow oil was purified by flash column chromatography (100 g silica, 3:1 → 2:1 pentane-MTBE) giving 1.35 g (90%) of the corresponding alkene. The colourless oil solidified on standing at r.t. R
f
= 0.19
(n-hexane-MTBE, 3:1); mp 76 °C; [α]D
20 +51.8 (c 3.29, CHCl3). IR (KBr): 578 (w), 598 (w), 698 (vs), 749 (s), 811 (w), 844 (w), 886 (w), 926 (m), 951 (w), 1028 (s), 1089 (vs), 1216 (s), 1308 (m), 1340 (m), 1396 (s), 1454 (s), 1496 (m), 2866 (m), 3031 (m), 3064 (m), 3472 (br m). 1H NMR (400 MHz, CDCl3): δ = 2.86 (d, 1 H, J = 10.7 Hz, OH), 3.76 (dd, 1 H, J = 2.4, 8.7 Hz, 4-H), 3.84 (br d, 1 H, J = 10.1 Hz, 2-H), 4.05 (dd, 1 H, J = 1.1, 11.8 Hz, 5-H), 4.08 (dd, 1 H, J = 2.2, 6.8 Hz, 1-Ha), 4.19 (dd, 1 H, J = 1.0, 8.7 Hz, 3-H), 4.24 (dd, 1 H, J = 2.0, 11.9 Hz, 1-Hb), 4.34 (d, 1 H, J = 12.1 Hz, PhCH
2), 4.69 (d, 1 H, J = 12.1 Hz, PhCH
2), 4.70 (d, 1 H, J = 10.9 Hz, PhCH
2), 4.78 (d, 1 H, J = 10.9 Hz, PhCH
2), 5.27-5.38 (m, 2 H, 7-H2), 5.40 (s, 1 H, PhCH), 5.96 (ddd, 1 H, J = 7.5, 10.2, 17.5 Hz, 6-H), 7.12-7.40 (m, 15 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 63.4 (C-6), 70.6 (PhCH2), 72.8 (C-7), 75.6 (PhCH2), 77.8 (C-5), 78.3 (C-3), 79.9 (C-4), 101.2 (PhCH), 118.6 (C-1), 126.0 (2 C), 127.7, 127.9, 128.2 (2 C), 128.3 (2 C), 2 × 128.4 (4 C), 128.6 (2 C), 129.0 (CHarom), 136.1 (C-2), 137.9, 138.3, 138.5 (Cq arom). HRMS (ESI): m/z calcd for C28H30NaO5 [M + Na+]: 469.1985; found: 469.1978.
Preparation of (1
S
,3
R
,4
S
,5
S
,6
R
)-1-Azidomethyl-3-(
tert
-butyldiphenylsilyloxymethyl)-5,6-dibenzyloxy-2,7-dioxabicyclo[2.2.1]heptane (9).
Powdered molecular sieves (2.30 g, 4 Å) were dried by heating in vacuo. Subsequently, 45 mL dry CH2Cl2 and 2.30 g (3.19 mmol) of ketone 8 were added. After the starting material had dissolved, 45 mL TFA were added in one portion at r.t. resulting in a yellow reaction mixture. TLC indicated complete conversion of the starting material within 25 min. The suspension was cooled to 0 °C, 20 mL dry toluene were added and the solvents were evaporated at the same temperature. The remaining solid was coevaporated twice with 10 mL dry toluene to remove traces of TFA. The pale pink crude product was purified by flash column chromatography (200 g silica, 7:1 pentane-MTBE) to yield 1.80 g (89%) of the bicyclic ketal 9 as colourless oil. R
f
= 0.36 (n-hexane-MTBE, 3:1); [α]D
20 -1.1 (c 4.89, CHCl3). IR (film): 607 (m), 700 (s), 739 (m), 823 (m), 998 (w), 1113 (s), 1283 (w), 1361 (w), 1428 (m), 1472 (w), 2104 (s), 2857 (m), 2930 (m), 3069 (w). 1H NMR (500 MHz, CDCl3): δ = 1.06 [s, 9 H, C(CH3)3], 3.40 (d, 1 H, J = 13.7 Hz, CH
a
HbN3), 3.55 (d, 1 H, J = 13.7 Hz, CHa
H
b
N3), 3.57 (d, 1 H, J = 9.4 Hz, CH
a
HbOR), 3.61-3.66 (m, 2 H, CHa
H
b
OR, 6-H), 3.80 (dd, 1 H, J = 9.2, 4.6 Hz, 3-H), 3.82 (t, 1 H, J = 1.5 Hz, 5-H), 4.45 (d, 1 H, J = 11.9 Hz, PhCH
2), 4.53 (d, 1 H, J = 11.7 Hz, PhCH
2), 4.55 (d, 1 H, J = 12.4 Hz, PhCH
2), 4.58 (d, 1 H, J = 12.4 Hz, PhCH
2), 4.74 (d, 1 H, J = 1.6 Hz, 4-H), 7.28-7.45 (m, 16 H, Harom), 7.59-7.65 (m, 4 H, Harom). 13C NMR (125 MHz, CDCl3): δ = 19.4 [C(CH3)3], 27.0 [C(CH3)3], 48.7 (CH2N3), 63.1 (CH2OR), 71.4, 73.1 (PhCH2), 77.2 (C-3), 81.1 (C-4), 83.6 (C-6), 87.4 (C-5), 106.9 (C-1), 127.9 (2C), 2 × 128.0 (4 C), 128.2, 128.3 (3 C), 2 × 128.7 (4 C), 130.0 (2 C, CHarom), 133.3, 133.4 (Cq arom), 135.6 (4 C, CHarom), 137.4, 137.5 (Cq arom). HRMS (ESI): m/z calcd for C37H41N3NaO5Si [M + Na+]: 658.2708; found: 658.2701.
Preparation of (1
R
,3
S
,4
R
,5
R
,6
R
)-1-Aminomethyl-5,6-dihydroxy-2,7-dioxabicyclo[2.2.1]heptane-3-carboxylic Acid (1).
The amount of 120 mg (0.292 mmol, 1.0 equiv) of the azide 10 was dissolved under argon in 25 mL EtOAc-MeOH 2:1 (v/v, HPLC grade). Then, 819 mg (0.584 mmol, 2.0 equiv) Pd(OH)2/C (wet, 20% Pd on dry basis, Degussa type E101 NE/W) were added, and the flask was evacuated five times with subsequent hydrogen insertion. Complete conversion was achieved within 90 min. The reaction mixture was filtered through a short column of Celite® and it was washed with 5 × 5 mL MeOH. Evaporation to dryness gave 60 mg (quant.) of the title compound 1 as white foam in pure form. In order to get a powder for better handling, the foam was dissolved in 1 mL MeOH and precipitated by slow addition of 4 mL EtOAc. The suspension was centrifuged and the supernatant was decanted. The resulting white solid was washed with 4 mL Et2O and dried in vacuo. R
f
= 0.26
(n-BuOH-H2O-HOAc 2:1:1); mp 140 °C (dec.); [α]D
20 +45.1 (c 0.35, H2O). IR (KBr): 696 (w), 824 (w), 958 (m), 1035 (w), 1072 (m), 1170 (w), 1307 (w), 1429 (m), 1510 (w), 1602 (s), 2925 (m), 3401 (br vs). 1H NMR (500 MHz, DMSO): δ = 3.19 (d, 1 H, J = 13.9 Hz, CH
a
HbNH2), 3.24 (d, 1 H, J = 13.7 Hz, CHa
H
b
NH2), 3.60 (s, 1 H, 5-H), 3.71 (d, 1 H, J = 1.6 Hz, 6-H), 3.96 (s, 1 H, 3-H), 4.42 (s, 1 H, 4-H). 13C NMR (100 MHz, DMSO): δ = 36.6 (CH2NH2), 73.9 (C-3), 77.0 (C-6), 82.3 (C-5), 86.5 (C-4), 106.5 (C-1), 171.3 (COOH). HRMS (ESI): m/z calcd for C7H12NO6 [M + H+]: 206.0659; found: 206.0660.
The crystal data of 1 has been deposited in the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 295618. Crystal Data: C7H11NO6, M = 205.17, monoclinic, P21, a = 4.9367 (6) Å, b = 13.0534 (19) Å, c = 7.0289 (8) Å, α = 90°, β = 91.297 (13)°, γ = 90°, V = 452.83 (10) Å3, Z = 2, D calcd = 1.505 g/cm3, 4497 collected reflections, 1760 independent (R int = 0.0347), R1 = 0.0274, wR2 = 0.0703 (all data).